News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,144 signal articles · 108 in last 24h · 178,660 total before filter · latest 52m ago

108last 24h

3128last 7d

512● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1822 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: ABCLSentiment:bullish neutral bearish show all (incl. clickbait)

MT Newswires9d agobullish

Jefferies & Co Initiates Coverage on AbCellera Biologics With Buy Rating, $21 Price Target

ABCL

MT Newswires27d agobullish

UBS Initiates AbCellera Biologics at Buy With $18 Price Target

ABCL

MT Newswires87d agoneutral

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Producer Inflation Data Release

ABCL CSCO GLD IGV IVV IWM LUNR QQQ+6

Motley Fool88d agoneutral

AbCellera (ABCL) Q2 2026 Earnings Call Transcript

ABCL

Stocktwits90d agoneutral

Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today?

ABCL ABNB

Bloomberg90d agoneutral

Hot-Flash Drug Trial Result Sends AbCellera Up as Much as 41%

ABCL PLTR

GuruFocus.com90d agobullish

AbCellera Stock Jumps 33% on a Positive Menopause Trial

ABCL

GuruFocus.com94d agoneutral

AbCellera Biologics Inc (ABCL) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress and ...

ABCL VRTX

Zacks95d agoneutral

AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Lags Revenue Estimates

ABCL

MarketBeat95d agoneutral

AbCellera Biologics Q2 Earnings Call Highlights

ABCL VRTX

MT Newswires144d agoneutral

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Ahead of Fed Rates Announcement

ABCL GLD IGV IVV IWM NOK QQQ SOXX+5

GuruFocus.com180d agoneutral

AbCellera Biologics Inc (ABCL) Q1 2026 Earnings Call Highlights: Promising Advancements Amid ...

ABCL

MarketBeat181d agoneutral

AbCellera Biologics Q1 Earnings Call Highlights

ABCL

Motley Fool181d agoneutral

AbCellera (ABCL) Q1 2026 Earnings Transcript

ABCL

Zacks181d agobullish

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue Estimates

ABCL